| Disease | renal cell carcinoma |
| Comorbidity | C0027726|nephrotic syndrome |
| Sentences | 1 |
| PubMedID- 24872478 | Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma. |
Page: 1